ARCH Venture Partners XII, LLC - 10%+ Owner at Neumora Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Company
Role: 10%+ Owner
Stock Symbol: NMRA on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

ARCH Venture Partners XII, LLC - trading volume in the past year for Neumora Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+1.92M	100%	$2.61	+$5M
Sells
Net	+1.92M	100%		+$5M

Holdings reported by ARCH Venture Partners XII, LLC for Neumora Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	12.2M	$22.2M	$1.82	Oct 27, 2025	By ARCH Venture Fund X, L.P.
Common Stock	11.9M	$21.6M	$1.82	Oct 27, 2025	By ARCH Venture Fund X Overage, L.P.
Common Stock	6.05M	$15.8M	$2.61	Oct 27, 2025	By ARCH Venture Fund XII, L.P.
Common Stock	2.32M	$4.23M	$1.82	Oct 27, 2025	By ARCH Venture Fund VIII Overage, L.P.
Common Stock	1.39M	$2.52M	$1.82	Oct 27, 2025	By ARCH Venture Fund VII, L.P.

Transactions reported by ARCH Venture Partners XII, LLC for Neumora Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.